Sasaki Atsushi, Kawarabayashi Takeshi, Murakami Tetsuro, Matsubara Etsuro, Ikeda Masaki, Hagiwara Haruo, Westaway David, George-Hyslop Peter S, Shoji Mikio, Nakazato Yoichi
Department of Human Pathology, Gunma University Graduate School of Medicine, Gunma, Japan.
Brain Res. 2008 Jun 12;1214:159-68. doi: 10.1016/j.brainres.2008.02.084. Epub 2008 Mar 8.
The aim of this study is to clarify the relationship of microglia to phosphorylated tau accumulation and the characteristics of microglial activation in brain lesions of human tauopathies in comparison to mutant tau transgenic (TG) mice. We performed immunocytochemical analyses of brains from six patients with tauopathies, and 24 mice (18 TG mice expressing mutant tau P301L and six non-TG control mice, 11 to 27 months of age) using anti-tau antibodies and various microglial markers. In the tau TG, both semiquantitative severity ratings of microglial activation and an ultrastructural study were performed. In human tauopathies, Iba1- and major histocompatibility complex (MHC) class II-positive activated microglia increased in regions of phosphorylated tau (AT8) accumulation. The immunoreactivity of scavenger receptor class A (SRA) was present in some activated microglia, including phagocytic microglia in Alzheimer's disease (AD). Double-immunofluorescent analysis under a confocal microscope showed activated microglia at the vicinity of AT8-positive cells. Semiquantitative data of the TG and control mice indicated that the immunopositivity of AT8 was closely associated with the number of Iba1-positive microglia in the cortical area. Tau-associated microglia showed rare immunoreactivity for MHC class II antigen and SRA in the TG mice. Ultrastructurally, activated microglia with enlarged cytoplasm were located near neurons containing abnormal cytoskeletons. This comparative study of human tauopathies and tau TG mice indicated that microglial activation was closely related to phosphorylated tau accumulation, and that activated microglia of the TG mice may have the low expression of MHC class II and SRA compared with those of human tauopathies.
本研究的目的是阐明与突变型tau转基因(TG)小鼠相比,小胶质细胞与人类tau蛋白病脑损伤中磷酸化tau蛋白积累的关系以及小胶质细胞活化的特征。我们使用抗tau抗体和各种小胶质细胞标记物,对6例tau蛋白病患者以及24只小鼠(18只表达突变型tau P301L的TG小鼠和6只非TG对照小鼠,年龄在11至27个月之间)的大脑进行了免疫细胞化学分析。在tau TG小鼠中,进行了小胶质细胞活化的半定量严重程度评级和超微结构研究。在人类tau蛋白病中,在磷酸化tau(AT8)积累区域,离子钙结合衔接分子1(Iba1)和主要组织相容性复合体(MHC)II类阳性活化小胶质细胞增加。A类清道夫受体(SRA)的免疫反应性存在于一些活化小胶质细胞中,包括阿尔茨海默病(AD)中的吞噬性小胶质细胞。共聚焦显微镜下的双重免疫荧光分析显示,AT8阳性细胞附近有活化的小胶质细胞。TG小鼠和对照小鼠的半定量数据表明,AT8的免疫阳性与皮质区域Iba1阳性小胶质细胞的数量密切相关。在TG小鼠中,与tau相关的小胶质细胞对MHC II类抗原和SRA的免疫反应性罕见。在超微结构上,细胞质扩大的活化小胶质细胞位于含有异常细胞骨架的神经元附近。这项对人类tau蛋白病和tau TG小鼠的比较研究表明,小胶质细胞活化与磷酸化tau蛋白积累密切相关,并且与人类tau蛋白病相比,TG小鼠的活化小胶质细胞可能具有较低的MHC II类和SRA表达。
J Neuroinflammation. 2018-11-9
J Neuroinflammation. 2012-9-18
Front Cell Neurosci. 2024-12-12
Front Aging Neurosci. 2024-10-21
Signal Transduct Target Ther. 2023-9-22
Pharmaceuticals (Basel). 2023-4-7